The article " 2 Generic Drug Stocks Ready to Surge in 2025 " first appeared on MarketBeat.

The timing of NICE’s review of the Aimovig verdict is unclear, and with Ajovy’s final guidance expected to be published next month Teva has an opportunity to access the NHS England market ...

Today, Benzinga's options scanner spotted 25 options trades for Teva Pharmaceutical Indus. This is not a typical pattern. The sentiment among these major traders is split, with 24% bullish and 60% ...

AJOVY at 21% is our global driver ... We're pleased with the fact that our Prolia biosimilar has been accepted for review by ...

Vydura adds to the stable of CGRP-targeting drugs available to NHS patients in England and Wales, with three injectables – Novartis’ Aimovig (erenumab), Teva’s Ajovy (fremanezumab), and Eli ...

Sales growth was mainly driven by higher revenues from generic products globally and strong growth from branded drugs, Austedo, Ajovy and Uzedy. Sales of certain product rights in Europe and ...

EPS: Up 16%. Free Cash Flow: $922 million. AUSTEDO Revenue: $435 million, 28% growth. AJOVY Revenue: 21% growth. UZEDY Revenue: $35 million in Q3, year-to-date $75 million. Global Generics Growth ...

Here are the year’s notable fiction, poetry and nonfiction, chosen by the staff of The New York Times Book Review. By The New York Times Books Staff “The New India,” by Rahul Bhatia ...

By David Stout New Horror Novels That Chill and Entertain Our columnist reviews books with lessons about perseverance, an undead girl and bizarre food. “If I come across ‘Dad’ or ‘Mommy ...

Join former prosecutor Andy McCarthy as he delves into the legal ins and outs of the latest Washington dramas with National Review editor in chief Rich Lowry. Capital Record – your weekly ...

You may have seen the following disclosure on all of our business, commercial, and financial product and services reviews and recommendations. It reads: "We independently evaluate all recommended ...

A high power conversion efficiency of 26.4% has been achieved for tandem solar cells that consist of a wide-bandgap perovskite cell and an organic cell. This feat was made possible through an ...